Nuveen Asset Management’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.69M | Buy |
653,428
+378,322
| +138% | +$1.56M | ﹤0.01% | 2259 |
|
|
2024
Q3 | $1.95M | Sell |
275,106
-171,702
| -38% | -$1.22M | ﹤0.01% | 2424 |
|
|
2024
Q2 | $2.91M | Buy |
446,808
+184,925
| +71% | +$1.21M | ﹤0.01% | 2199 |
|
|
2024
Q1 | $2.17M | Hold |
261,883
| – | – | ﹤0.01% | 2367 |
|
|
2023
Q4 | $2.88M | Buy |
261,883
+3,413
| +1% | +$37.6K | ﹤0.01% | 2239 |
|
|
2023
Q3 | $2.17M | Sell |
258,470
-1,612
| -0.6% | -$13.6K | ﹤0.01% | 2264 |
|
|
2023
Q2 | $3.27M | Buy |
260,082
+9,145
| +4% | +$115K | ﹤0.01% | 2114 |
|
|
2023
Q1 | $4.13M | Buy |
250,937
+15,734
| +7% | +$259K | ﹤0.01% | 1996 |
|
|
2022
Q4 | $3.51M | Sell |
235,203
-38,975
| -14% | -$582K | ﹤0.01% | 2114 |
|
|
2022
Q3 | $6.13M | Buy |
274,178
+4,332
| +2% | +$96.9K | ﹤0.01% | 1779 |
|
|
2022
Q2 | $4.52M | Buy |
269,846
+52,523
| +24% | +$880K | ﹤0.01% | 2011 |
|
|
2022
Q1 | $5.63M | Buy |
217,323
+5,272
| +2% | +$137K | ﹤0.01% | 1995 |
|
|
2021
Q4 | $5.93M | Sell |
212,051
-2,167
| -1% | -$60.6K | ﹤0.01% | 2025 |
|
|
2021
Q3 | $7.95M | Buy |
214,218
+6,707
| +3% | +$249K | ﹤0.01% | 1944 |
|
|
2021
Q2 | $7.59M | Buy |
207,511
+50,977
| +33% | +$1.87M | ﹤0.01% | 2020 |
|
|
2021
Q1 | $5.41M | Buy |
156,534
+27,843
| +22% | +$962K | ﹤0.01% | 2135 |
|
|
2020
Q4 | $5.35M | Buy |
128,691
+2,652
| +2% | +$110K | ﹤0.01% | 2039 |
|
|
2020
Q3 | $5.37M | Buy |
+126,039
| New | +$5.37M | ﹤0.01% | 1879 |
|